Analysis of Overall Survival in Patients with Nonmetastatic Castration-Resistant Prostate Cancer Treated with Vaccine, Nilutamide, and Combination Therapy: Implications for Vaccine Clinical Trial Design

PURPOSE: We previously reported the first randomized study of any kind in patients with nonmetastatic, castrate-resistant prostate cancer. The study employed vaccine, the hormone nilutamide, and the combined therapy (crossover for each arm) with an endpoint of time to progression. We now report surv...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Madan, Ravi A., Gulley, James L., Schlom, Jeffrey, Steinberg, Seth M., Liewehr, David J., Dahut, William L., Arlen, Philip M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2008
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2682417/
https://ncbi.nlm.nih.gov/pubmed/18628467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-07-5048
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items